BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety, activity and best doses of FOLFOX-A which
consists of the standard chemotherapy drugs fluorouracil, leucovorin, oxaliplatin and
abraxane. Each of these drugs are currently used in pancreatic cancer.
The experimental part of the study is combining these drugs together in FOLFOX-A.
Phase:
Phase 1
Details
Lead Sponsor:
Brown University
Collaborators:
Lifespan Memorial Hospital of Rhode Island Rhode Island Hospital